The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells
出版年份 2019 全文链接
标题
The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells
作者
关键词
-
出版物
Cancers
Volume 11, Issue 11, Pages 1678
出版商
MDPI AG
发表日期
2019-10-31
DOI
10.3390/cancers11111678
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
- (2019) Michael-Antony Lisio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer Metabolism: a Hope for Curing Cancer
- (2018) Soo-Youl Kim Biomolecules & Therapeutics
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Personalising Treatment for High-Grade Serous Ovarian Carcinoma
- (2018) E. Cojocaru et al. CLINICAL ONCOLOGY
- Metabolic traits of cancer stem cells
- (2018) Joana Peixoto et al. Disease Models & Mechanisms
- Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
- (2018) Lan Thi Hanh Phi et al. Stem Cells International
- Cancer Stem Cell Metabolism and Potential Therapeutic Targets
- (2018) Vusala Snyder et al. Frontiers in Oncology
- Ovarian cancer stem cells: A target for oncological therapy
- (2018) Anna Markowska et al. Advances in Clinical and Experimental Medicine
- Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors
- (2018) Seema C. Parte et al. Journal of Ovarian Research
- PARP inhibition induces enrichment of DNA repair proficient CD133 and CD117 positive ovarian cancer stem cells
- (2018) Chiara Bellio et al. MOLECULAR CANCER RESEARCH
- Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells
- (2018) Nuzhat Ahmed et al. SEMINARS IN CANCER BIOLOGY
- Ovarian cancer stem cells: What progress have we made?
- (2018) Linah F. Al-Alem et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial
- (2017) Angela Alistar et al. LANCET ONCOLOGY
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
- (2017) Sajad Dar et al. Scientific Reports
- Stem-like features of cancer cells on their way to metastasis
- (2016) Sofia Gkountela et al. Biology Direct
- Cancer stem cells
- (2016) Jeremy N. Rich MEDICINE
- Tumor-initiating cell frequency is relevant for glioblastoma aggressiveness
- (2016) Cristina Richichi et al. Oncotarget
- Metabolic phenotyping for monitoring ovarian cancer patients
- (2016) Chaofu Ke et al. Scientific Reports
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- Cancer Stem Cell Plasticity Drives Therapeutic Resistance
- (2016) Mary Doherty et al. Cancers
- Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance
- (2015) Xiaohui Wang et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- The metabolic state of cancer stem cells—a valid target for cancer therapy?
- (2015) Erina Vlashi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Targeted delivery of platinum-taxane combination therapy in ovarian cancer
- (2015) Swapnil S. Desale et al. JOURNAL OF CONTROLLED RELEASE
- Metabolic plasticity of cancer stem cells
- (2015) Ming Luo et al. Oncotarget
- Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
- (2015) Michele Cioffi et al. Scientific Reports
- Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
- (2015) Anna Pastò et al. Oncotarget
- A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies
- (2014) T. S. Pardee et al. CLINICAL CANCER RESEARCH
- Ovarian tumor-initiating cells display a flexible metabolism
- (2014) Angela S. Anderson et al. EXPERIMENTAL CELL RESEARCH
- Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
- (2014) Jianqun Liao et al. PLoS One
- Understanding and targeting cancer stem cells: therapeutic implications and challenges
- (2013) Ke Chen et al. ACTA PHARMACOLOGICA SINICA
- Acidic extracellular microenvironment and cancer
- (2013) Yasumasa Kato et al. Cancer Cell International
- Ovarian tumor initiating cell populations persist following paclitaxel and carboplatin chemotherapy treatment in vivo
- (2013) Kashmira Kulkarni-Datar et al. CANCER LETTERS
- The influence of pH and hypoxia on tumor metastasis
- (2013) Mariam Abaza et al. Expert Review of Anticancer Therapy
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- DNA Damage Repair Pathways in Cancer Stem Cells
- (2012) M. Maugeri-Sacca et al. MOLECULAR CANCER THERAPEUTICS
- Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
- (2011) Y. Zhao et al. CANCER RESEARCH
- Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
- (2011) Lijing Luo et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo
- (2011) Zuzana Zachar et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Metabolic state of glioma stem cells and nontumorigenic cells
- (2011) E. Vlashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug Treatment of Cancer Cell Lines: A Way to Select for Cancer Stem Cells?
- (2011) Ilaria Chiodi et al. Cancers
- Metabolic flexibility and cell hierarchy in metastatic cancer
- (2010) Michael V. Berridge et al. MITOCHONDRION
- Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
- (2010) Ming Zhou et al. Molecular Cancer
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
- (2009) Fatima Cardoso et al. JNCI-Journal of the National Cancer Institute
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
- (2009) Michael D. Curley et al. STEM CELLS
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
- Sequential Versus Combination Therapy: Where Are We?
- (2008) Edward Chu Clinical Colorectal Cancer
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now